Issue |
J Extra Corpor Technol
Volume 19, Number 3, September 1987
|
|
---|---|---|
Page(s) | 358 - 364 | |
DOI | https://doi.org/10.1051/ject/1987193358 | |
Published online | 29 August 2023 |
Original Article
Neutralization of Heparin Using a Protamine Titration Assay and the Activated Clotting Time Test
1
Minneapolis Heart Institute, Minneapolis, MN
2
John Hopkins Hospital, Baltimore, MD
3
International Technidyne Corporation, Edison, NJ
* Direct communications to: Dr. Frank LaDuca, Research Division, International Technidyne Corporation, 23 Nevsky St. Edison, NJ 08820
(J. Extra-Corpor. Technol. 19[3] p. 358-364 Fall 1987, 16 ref.) Many of the clinical protocols currently used to calculate the protamine (Pr) dosage for heparin neutralization following cardiopulmonary bypass (CPB) utilize an empirical Pr to heparin ratio. Prtitration, though a proven method of dosage calculation, is inherently tedious and thus not routinely used in the operating room (OR). In the present study Pr titration was performed by preparation of diatomaceous earth-activated clotting time (ACT) test tubes containing known amounts of lyophilized Pr. The ACT determined in these test tubes was called the P-ACT. The Pr titration curve was constructed using a status (heparinized) ACT (S-ACT) and P-ACT at Pr concentrations of 1 0, 15, 20 and 30 mcg/ml. The ACT was performed using an automated technique (Hemochron). The intercept of the linear regression dose-response neutralization curve (ACT vs Pr concentration) with the baseline ACT was the calculated Pr concentration required for neutralization. Addition of calculated Pr to in vitro heparinized donor blood normalized the ACT and non-activated clotting time (NACT). A two-point doseresponse curve (S-ACT and P-ACT, 15 mcg/ml) produced equivalent results to the linear regression dose-response calculation (r = .95). In 30 CPB patients infusion of the calculated Pr (based on the two-point assay and the patient's blood volume, adjusted for changes during CPB) normalized the ACT and produced clinical hemostasis. This assay provides a method of Pr quantification in the OR reducing the likelihood of over- or under-infusion of protamine and the adverse consequences associated with either.
Key words: activated clotting time / heparine / reversal / protamine: heparin / ratio
© 1987 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.